Clinical Trials Browser

Neoplasm Metastasis × etirinotecan pegol × Thoracic × Clear all

NCT01773109 2020-04-03

Etirinotecan Pegol (NKTR-102) in NSCLC

Phase 2 Completed

40 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis